Related Articles
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms
Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer
High p53 and MAP1 light chain 3A co-expression predicts poor prognosis in patients with esophageal squamous cell carcinoma
Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma
Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma